Our resource hub to discover reports, policy papers and other forms of informative content
IMC supports the creation of a Pan Canadian Genomics Strategy (PCGS) to help Canada advance its international leadership and increase capacity in genomics through commercialization and adoption.
IMC requests that the Honourable Patty Hadju suspend the July 1, 2021 implementation of regulatory changes to the PMPRB until the COVID-19 pandemic has abated.
IMC appears before the CIIT to support its study of Canada’s trade agreements and trade and investment policies regarding how they may help or hinder the production and distribution of COVID-19 vaccines domestically and abroad.
IMC and and BIOTECanada write to Suzanne McGurn with joint input on the current CADTH process consultation.
IMC comments on the notice of proposed rulemaking titled “Importation of Prescription Drugs” published by the U.S. Food and Drug Administration in the Federal Register, December 23, 2019.
IMC responds to PMPRB draft guidelines released November 21, 2019, stating a balance must be struck between budgetary pressures confronting Canadian governments and the preservation of Canadians’ timely access to life-saving innovative medicines.
Informative content to keep you up to date on the most pressing issues facing our industry.
